Steroplast Healthcare Limited - Period Ending 2019-03-31

Steroplast Healthcare Limited - Period Ending 2019-03-31


Steroplast Healthcare Limited 00504340 false 2018-04-01 2019-03-31 2019-03-31 The principal activity of the company is that of the distribution of occupational health, sports injury and clinical products. Digita Accounts Production Advanced 6.24.8820.0 Software true 00504340 2018-04-01 2019-03-31 00504340 2019-03-31 00504340 bus:Director1 1 2019-03-31 00504340 core:OtherReservesSubtotal 2019-03-31 00504340 core:RetainedEarningsAccumulatedLosses 2019-03-31 00504340 core:ShareCapital 2019-03-31 00504340 core:CurrentFinancialInstruments 2019-03-31 00504340 core:CurrentFinancialInstruments core:WithinOneYear 2019-03-31 00504340 core:Non-currentFinancialInstruments 2019-03-31 00504340 core:Non-currentFinancialInstruments core:AfterOneYear 2019-03-31 00504340 core:MoreThanFiveYears 1 2019-03-31 00504340 core:FurnitureFittings 2019-03-31 00504340 core:LandBuildings core:LongLeaseholdAssets 2019-03-31 00504340 core:MotorVehicles 2019-03-31 00504340 core:PlantMachinery 2019-03-31 00504340 bus:SmallEntities 2018-04-01 2019-03-31 00504340 bus:AuditExemptWithAccountantsReport 2018-04-01 2019-03-31 00504340 bus:FullAccounts 2018-04-01 2019-03-31 00504340 bus:SmallCompaniesRegimeForAccounts 2018-04-01 2019-03-31 00504340 bus:RegisteredOffice 2018-04-01 2019-03-31 00504340 bus:Director1 2018-04-01 2019-03-31 00504340 bus:Director1 1 2018-04-01 2019-03-31 00504340 bus:PrivateLimitedCompanyLtd 2018-04-01 2019-03-31 00504340 core:Buildings 2018-04-01 2019-03-31 00504340 core:FurnitureFittings 2018-04-01 2019-03-31 00504340 core:LandBuildings core:LongLeaseholdAssets 2018-04-01 2019-03-31 00504340 core:MotorVehicles 2018-04-01 2019-03-31 00504340 core:PlantMachinery 2018-04-01 2019-03-31 00504340 countries:England 2018-04-01 2019-03-31 00504340 2018-03-31 00504340 core:FurnitureFittings 2018-03-31 00504340 core:LandBuildings core:LongLeaseholdAssets 2018-03-31 00504340 core:MotorVehicles 2018-03-31 00504340 core:PlantMachinery 2018-03-31 00504340 2017-04-01 2018-03-31 00504340 2018-03-31 00504340 bus:Director1 1 2018-03-31 00504340 core:OtherReservesSubtotal 2018-03-31 00504340 core:RetainedEarningsAccumulatedLosses 2018-03-31 00504340 core:ShareCapital 2018-03-31 00504340 core:CurrentFinancialInstruments 2018-03-31 00504340 core:CurrentFinancialInstruments core:WithinOneYear 2018-03-31 00504340 core:Non-currentFinancialInstruments 2018-03-31 00504340 core:Non-currentFinancialInstruments core:AfterOneYear 2018-03-31 00504340 core:MoreThanFiveYears 1 2018-03-31 00504340 core:FurnitureFittings 2018-03-31 00504340 core:LandBuildings core:LongLeaseholdAssets 2018-03-31 00504340 core:MotorVehicles 2018-03-31 00504340 core:PlantMachinery 2018-03-31 00504340 bus:Director1 1 2017-04-01 2018-03-31 iso4217:GBP xbrli:pure

Registration number: 00504340

Steroplast Healthcare Limited

Unaudited Financial Statements

for the Year Ended 31 March 2019

 

Steroplast Healthcare Limited

Contents

Statement of Financial Position

1 to 2

Notes to the Financial Statements

3 to 8

 

Steroplast Healthcare Limited

(Registration number: 00504340)
Statement of Financial Position as at 31 March 2019

Note

2019
£

2018
£

Fixed assets

 

Tangible assets

4

996,954

986,815

Investment property

5

400,559

396,690

 

1,397,513

1,383,505

Current assets

 

Stocks

1,109,242

1,216,393

Debtors

6

1,067,806

1,007,387

Cash at bank and in hand

 

483,775

105,206

 

2,660,823

2,328,986

Creditors: Amounts falling due within one year

7

(849,089)

(650,238)

Net current assets

 

1,811,734

1,678,748

Total assets less current liabilities

 

3,209,247

3,062,253

Creditors: Amounts falling due after more than one year

7

(295,906)

(310,475)

Provisions for liabilities

(23,479)

(33,638)

Net assets

 

2,889,862

2,718,140

Capital and reserves

 

Called up share capital

76,756

76,756

Other reserves

23,244

23,244

Profit and loss account

2,789,862

2,618,140

Shareholders funds

 

2,889,862

2,718,140

 

Steroplast Healthcare Limited

(Registration number: 00504340)
Statement of Financial Position as at 31 March 2019

For the financial year ending 31 March 2019 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Income Statement has been taken.

Approved and authorised by the Board on 30 October 2019 and signed on its behalf by:
 

.........................................

A C Brown
Director

 

Steroplast Healthcare Limited

Notes to the Financial Statements for the Year Ended 31 March 2019

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Alpha Point
Bradnor Road
Manchester
Lancashire
M22 4TE
United Kingdom

These financial statements were authorised for issue by the Board on 30 October 2019.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements for the year ended 31 March 2019 are the first financial statements to comply with FRS 102 Section 1A for small entities.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

Steroplast Healthcare Limited

Notes to the Financial Statements for the Year Ended 31 March 2019

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and machinery

20% reducing balance

Fixtures and fittings

25% and 15% reducing balance

Motor vehicles

25% on cost

Leasehold property

2% on cost

Investment property

Investment properties are revalued annually and any surplus or deficit is dealt with through profit and loss. No depreciation is provided in respect of investment properties.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the Income Statement over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.

Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the Statement of Financial Position as a finance lease obligation.

Lease payments are apportioned between finance costs in the Income Statement and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

 

Steroplast Healthcare Limited

Notes to the Financial Statements for the Year Ended 31 March 2019

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

Financial instruments

Classification
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
 
 

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 29 (2018 - 31).

4

Tangible assets

Long leasehold land and buildings
£

Fixtures and fittings
£

Plant and machinery
£

Motor vehicles
 £

Cost or valuation

At 1 April 2018

944,620

442,265

126,075

147,864

Additions

-

45,318

22,200

25,250

Disposals

-

-

-

(22,602)

At 31 March 2019

944,620

487,583

148,275

150,512

Depreciation

At 1 April 2018

160,670

339,860

109,518

63,961

Charge for the year

11,292

24,887

3,638

32,453

Eliminated on disposal

-

-

-

(12,243)

At 31 March 2019

171,962

364,747

113,156

84,171

Carrying amount

At 31 March 2019

772,658

122,836

35,119

66,341

At 31 March 2018

783,950

102,405

16,557

83,903

 

Steroplast Healthcare Limited

Notes to the Financial Statements for the Year Ended 31 March 2019

Total
£

Cost or valuation

At 1 April 2018

1,660,824

Additions

92,768

Disposals

(22,602)

At 31 March 2019

1,730,990

Depreciation

At 1 April 2018

674,009

Charge for the year

72,270

Eliminated on disposal

(12,243)

At 31 March 2019

734,036

Carrying amount

At 31 March 2019

996,954

At 31 March 2018

986,815

Included within the net book value of land and buildings above is £772,658 (2018 - £783,950) in respect of long leasehold land and buildings.
 

5

Investment properties

2019
£

At 1 April

396,690

Additions

3,869

At 31 March

400,559

The director, Mr A C Brown, does not believe that there has been any significant change in the value of the property since it was purchased and refurbished during the year.

There has been no valuation of investment property by an independent valuer.

6

Debtors

2019
£

2018
£

Trade debtors

936,543

891,536

Other debtors

131,263

115,851

1,067,806

1,007,387

 

Steroplast Healthcare Limited

Notes to the Financial Statements for the Year Ended 31 March 2019

7

Creditors

Creditors: amounts falling due within one year

Note

2019
£

2018
£

Due within one year

 

Bank loans and overdrafts

8

27,171

18,966

Trade creditors

 

650,590

366,188

Taxation and social security

 

73,022

59,334

Other creditors

 

98,306

205,750

 

849,089

650,238

Creditors: amounts falling due after more than one year

Note

2019
£

2018
£

Due after one year

 

Loans and borrowings

8

295,906

310,475

2019
£

2018
£

After more than five years by instalments

203,800

227,137

-

-

8

Loans and borrowings

2019
£

2018
£

Non-current loans and borrowings

Bank borrowings

289,849

310,475

Hire purchase liabilities

6,057

-

295,906

310,475

2019
£

2018
£

Current loans and borrowings

Bank borrowings

19,903

18,966

Hire purchase liabilities

7,268

-

27,171

18,966

The bank loan is secured by way of a legal mortgage over the leasehold property to which it relates.

 

Steroplast Healthcare Limited

Notes to the Financial Statements for the Year Ended 31 March 2019

9

Related party transactions

Transactions with directors

2019

At 1 April 2018
£

Advances to directors
£

At 31 March 2019
£

A C Brown

General personal expenses

51,035

13,435

64,470

       
     

 

2018

At 1 April 2017
£

Advances to directors
£

At 31 March 2018
£

A C Brown

General personal expenses

7,051

43,984

51,035